Cancer Research includes companies working on scientific research aimed at understanding the causes, prevention, diagnosis, treatment, and potential cures for cancer. It includes many disciplines, from biology and genetics, to clinical trials and drug development, with the ultimate goal of improving cancer care and outcomes. Cancer research companies are developing life-saving treatments and diagnostics for a growing market in high demand. These companies constantly innovate, have a global reach, and form important strategic partnerships, which makes them appealing to investors looking for profits and supporting health progress.
Earnings Call Summary | Exact Sciences(EXAS.US) Q1 2025 Earnings Conference
After-market Movers: Stock Futures up Despite Apple, Amazon Falling After Earnings
12 Health Care Stocks Moving In Thursday's After-Market Session
Exact Sciences Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Sales Results and Raised Its FY25 Sales Guidance.
Exact Sciences Raises FY2025 Sales Guidance From $3.02B-3.08B to $3.07B-3.12B
Correction: Exact Sciences Q1 Adj. EPS $(0.54) Misses $(0.38) Estimate, Sales $707.00M Beat $688.64M Estimate